Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Operating Officer | May 12, 2025 | May 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date May 12, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 805,083 |
Ending reported balance
After 2025-05-12 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2025-05-12 · Exercise / conversion · Acquired 33,333 · Balance 838,416 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. Row 2 · 2025-05-12 · Sale · Disposed 13,786 · Balance 824,630 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 3 · 2025-05-12 · Sale · Disposed 6,801 · Balance 817,829 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 4 · 2025-05-12 · Sale · Disposed 7,556 · Balance 810,273 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 5 · 2025-05-12 · Sale · Disposed 5,190 · Balance 805,083 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2030-05-13 | Direct | 693,795 |
Reported balance
After 2025-05-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-12 · Exercise / conversion · Disposed 33,333 · Balance 693,795 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.
F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2023 Filed Sep 19, 2023 14:05 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 20,683 | $6.31 | $130,509.73 |
DisclosureSEC source: 0001773751-23-000244 · wk-form4_1695146704.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,248 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 14:05 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 52,579 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000244 · wk-form4_1695146704.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 19:48 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $6.87 | $62,729.10 |
DisclosureSEC source: 0001773751-23-000232 · wk-form4_1694044071.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 399,352 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.775 - $6.93. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 19:48 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $6.80 | $62,135.45 |
DisclosureSEC source: 0001773751-23-000232 · wk-form4_1694044071.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,485 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.65 - $6.925. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 19:48 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $6.87 | $62,740.06 |
DisclosureSEC source: 0001773751-23-000232 · wk-form4_1694044071.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 417,618 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.78 - $6.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 16:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $8.00 | $73,052.13 |
DisclosureSEC source: 0001773751-23-000209 · wk-form4_1691526151.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,751 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $7.85 - $8.35. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 16:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $8.18 | $74,731.69 |
DisclosureSEC source: 0001773751-23-000206 · wk-form4_1691439739.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 435,884 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.055 - $8.255. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 16:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $8.26 | $75,468.72 |
DisclosureSEC source: 0001773751-23-000206 · wk-form4_1691439739.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 445,017 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.190 - $8.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 16:17 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 9,133 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-23-000195 · wk-form4_1689020229.xml · derivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 841,687 Underlying: Class A Common Stock · 9,133 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 16:17 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $8.68 | $79,282.66 |
DisclosureSEC source: 0001773751-23-000195 · wk-form4_1689020229.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,150 F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.595 - $8.735. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 16:17 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,133 | $0.40 | $3,653.20 |
DisclosureSEC source: 0001773751-23-000195 · wk-form4_1689020229.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 463,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 16:44 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 9,133 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 850,820 Underlying: Class A Common Stock · 9,133 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 16:44 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $8.88 | $81,113.83 |
DisclosureSEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,150 F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.705 - $9.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 16:44 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,133 | $0.40 | $3,653.20 |
DisclosureSEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 463,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 16:44 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 9,133 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 859,953 Underlying: Class A Common Stock · 9,133 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 16:44 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $9.19 | $83,894.82 |
DisclosureSEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,150 F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.085 - $9.44. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 16:44 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,133 | $0.40 | $3,653.20 |
DisclosureSEC source: 0001773751-23-000193 · wk-form4_1688676266.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 463,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 13 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28 Underlying: Class A Common Stock · 14 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019. F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 12 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,385 Underlying: Class A Common Stock · 692 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019. F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after December 15, 2019. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 4,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,290 Underlying: Class A Common Stock · 4,763 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285 Underlying: Class A Common Stock · 94 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,552 Underlying: Class A Common Stock · 1,221 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,380 Underlying: Class A Common Stock · 1,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 8,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,067 Underlying: Class A Common Stock · 8,295 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340 Underlying: Class A Common Stock · 48 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,681 Underlying: Class A Common Stock · 811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,839 Underlying: Class A Common Stock · 18,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 16,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · derivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,459 Underlying: Class A Common Stock · 16,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 20,682 | $8.80 | $182,001.60 |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,150 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:53 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 52,572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-23-000169 · wk-form4_1687294366.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 19:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 9,133 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 869,086 Underlying: Class A Common Stock · 9,133 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 19:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $9.12 | $83,260.99 |
DisclosureSEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,260 F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.955 - $9.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 19:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,133 | $0.40 | $3,653.20 |
DisclosureSEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 431,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 19:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 2,481 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 878,219 Underlying: Class A Common Stock · 2,481 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 19:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $9.08 | $82,950.47 |
DisclosureSEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,260 F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.88 - $9.205. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 19:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 2,481 | $0.40 | $992.40 |
DisclosureSEC source: 0001773751-23-000161 · wk-form4_1686267077.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 431,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 17:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $8.89 | $81,201.50 |
DisclosureSEC source: 0001773751-23-000157 · wk-form4_1686173507.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,412 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.79 - $8.985. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 19, 2023 Filed Jun 7, 2023 17:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 2,500 | $3.00 | $7,500.00 |
DisclosureSEC source: 0001773751-23-000157 · wk-form4_1686173507.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 428,912 F3 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the Purchase Period (as defined in the ESPP) of November 21, 2022 through May 20, 2023. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the issuer's common stock on May 23, 2022. Read SEC document |
| May 10, 2023 Filed May 11, 2023 14:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 12,966 | $0.40 Strike: $0.40 | $5,186.40 |
DisclosureSEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 880,700 Underlying: Class A Common Stock · 12,966 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| May 10, 2023 Filed May 11, 2023 14:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 12,966 | $0.40 | $5,186.40 |
DisclosureSEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 435,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| May 09, 2023 Filed May 11, 2023 14:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 12,966 | $0.40 Strike: $0.40 | $5,186.40 |
DisclosureSEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 893,666 Underlying: Class A Common Stock · 12,966 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| May 09, 2023 Filed May 11, 2023 14:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $10.78 | $98,496.67 |
DisclosureSEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,579 F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.52 - $11.425. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 09, 2023 Filed May 11, 2023 14:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,833 | $10.78 | $41,310.16 |
DisclosureSEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 431,712 F2 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.51 - $11.48. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 09, 2023 Filed May 11, 2023 14:04 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 12,966 | $0.40 | $5,186.40 |
DisclosureSEC source: 0001773751-23-000131 · wf-form4_168382824358334.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 435,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| May 08, 2023 Filed May 9, 2023 18:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 19,032 | $0.40 | $7,612.80 |
DisclosureSEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. Read SEC document |
| May 08, 2023 Filed May 9, 2023 18:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,833 | $11.83 | $45,335.57 |
DisclosureSEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,547 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.73 - $12.00. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2023 Filed May 9, 2023 18:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $11.83 | $108,013.25 |
DisclosureSEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 407,380 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.69 - $12.03. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 05, 2023 Filed May 9, 2023 18:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 19,032 | $0.40 Strike: $0.40 | $7,612.80 |
DisclosureSEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 906,632 Underlying: Class A Common Stock · 19,032 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| May 05, 2023 Filed May 9, 2023 18:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,899 | $12.04 | $119,182.97 |
DisclosureSEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 416,513 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.76 - $12.245. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 05, 2023 Filed May 9, 2023 18:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,133 | $12.04 | $109,950.36 |
DisclosureSEC source: 0001773751-23-000129 · wf-form4_168367054093060.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,412 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2022 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.74 - $12.23. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.